Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung

Lung Cancer

Volumn 76, Issue 3, 2012, Pages 423-430

  Taira, Tetsuhiko ^a,b   Ishii, Genichiro ^a   Nagai, Kanji ^a   Yoh, Kiyotaka ^a   Takahashi, Yusuke ^a   Matsumura, Yuki ^a   Kojima, Motohiro ^a   Ohmatsu, Hironobu ^a   Goto, Koichi ^a   Niho, Seiji ^a   Takashima, Hiroshi ^b   Inoue, Hiromasa ^b   Ohe, Yuichiro ^a   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Epithelial Mesenchymal Transition (EMT); Lung cancer; Prognostic factor; Squamous cell carcinoma; Tumor budding

Indexed keywords

BETA CATENIN; UVOMORULIN;

AGED; ARTICLE; CANCER INFILTRATION; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR BUDDING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, GROWTH FACTOR;

EID: 84860508366     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.11.010     Document Type: Article

References (26)

1. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
2. Mok T.S., Wu Y.L., Thongprasert S., Yang C.H., Chu D.T., Saijo N., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009, 361:947-957.
3. Rosell R., Moran T., Queralt C., Porta R., Cardenal F., Camps C., et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009, 361:958-967.
4. Jassem J., Langer C.J., Karp D.D., Mok T., Benner R.J., Green S.J., et al. Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC). J Clin Oncol 2010, 28(15s):7500.
5. Morodomi T., Isomoto H., Shirouzu K., Kakegawa K., Irie K., Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989, 63:539-543.
6. Hase K., Shatney C., Johnson D., Trollope M., Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993, 36:627-635.
7. Yamaguchi Y., Ishii G., Kojima M., Yoh K., Otsuka H., Otaki Y., et al. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness. J Thorac Oncol 2010, 5:1361-1368.
8. Kanazawa H., Mitomi H., Nishiyama Y., Kishimoto I., Fukui N., Nakamura T., et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis 2008, 10:41-47.
9. Wang L.M., Kevans D., Mulcahy H., O'Sullivan J., Fennelly D., Hyland J., et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 2009, 33:134-141.
10. Suzuki K., Nagai K., Yoshida J., Nishimura M., Takahashi K., Yokose T., et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 1999, 86:1976-1984.
11. Shimizu K., Yoshida J., Nagai K., Nishimura M., Ishii G., Morishita Y., et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005, 130:160-165.
12. Naito Y., Goto K., Nagai K., Ishii G., Nishimura M., Yoshida J., et al. Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer. Chest 2010, 138:1411-1417.
13. Maeshima A.M., Maeshima A., Asamura H., Matsuno Y. Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung. Lung Cancer 2006, 52:53-58.
14. El-Bahrawy M.A., Poulsom R., Jeffery R., Talbot I., Alison M.R. The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum Pathol 2001, 32:1216-1224.
15. Shinto E., Tsuda H., Ueno H., Hashiguchi Y., Hase K., Tamai S., et al. Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest 2005, 85:257-266.
16. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007, 50:151-162.
17. Zlobec I., Lugli A. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 2009, 15:5898-5906.
18. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
19. Aokage K., Ishii G., Ohtaki Y., Yamaguchi Y., Hishida T., Yoshida J., et al. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2010, 128:1585-1595.
20. McGarry T.J., Kirschner M.W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998, 93:1043-1053.
21. Wohlschlegel J.A., Kutok J.L., Weng A.P., Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol 2002, 161:267-273.
22. Sordat I., Rousselle P., Chaubert P., Petermann O., Aberdam D., Bosman F.T., et al. Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment. Int J Cancer 2000, 88:708-717.
23. Masaki T., Matsuoka H., Sugiyama M., Abe N., Goto A., Sakamoto A., et al. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 2001, 84:1317-1321.
24. Oku Y., Shimoji T., Takifuji K., Hotta T., Yokoyama S., Matsuda K., et al. Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis. Clin Cancer Res 2008, 14:7215-7222.
25. JCE U General and systematic pathology 1994, Churchill Livingstone, New York, p. 343.
26. Kon-no H., Ishii G., Nagai K., Yoshida J., Nishimura M., Nara M., et al. Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer 2006, 54:409-418.